Featured Job
-
Job Removed or Not Found
Related Jobs
- Merck & Co. (Rahway, NJ)
- …Delineate the US medical modernization strategic focus and priorities across all V&I therapeutic areas (TAs) and oversee the E2E process of implementation of digital
- Novo Nordisk Inc. (Plainsboro, NJ)
- …Bachelors degree or equivalent required; MBA or equivalent preferred. A minimum of 12 years of progressively relevant corporate business strategy development and
- Novo Nordisk Inc. (Plainsboro, NJ)
- …Bachelor's degree or equivalent required; MBA preferred 10+ years of progressively relevant corporate business strategy development and planning, marketing and brand
- Daiichi Sankyo, Inc. (Bernards, NJ)
- …The TA Oncology Strategy and Execution Lead is a pivotal leadership role responsible for driving the strategic and operational effectiveness of this newly formed TA
- Merck & Co. (Rahway, NJ)
- …include assay development, representing the group on product development teams and supporting defining the potency strategy for a portion of our large molecule portfolio,
- Merck & Co. (Rahway, NJ)
- …include financial management, program law firm management, legal records and information management, legal technology strategy, learning and development initiatives, and
- Merck & Co. (Chicago, IL)
- …Function as an integral member of the Regional Leadership Team supporting territory managers by demonstrating and conveying the value and benefits of our company's Animal
- Tris Pharma (Monmouth Junction, NJ)
- …We have more than 150 US and International patents including applications and have marketed several branded and generic products in the US, have licensed our products in
- Merck & Co. (Rahway, NJ)
- …in biological science or related disciplineB.S., with minimum of 7 years of relevant drug development experienceM.S. with minimum of 5 years relevant drug development
- Merck & Co. (Rahway, NJ)
- …may include the development of custom host cell protein (HCP) reagents and highly sensitive immunoassays to monitor the clearance of problematic residual host cell